Are trial participants adequately safeguarded by the ethics committees-the Indian scenario?
作者信息
Thakkar Karan, Billa Gauri
机构信息
Clinical Pharmacologist, formerly affiliated to Department of Pharmacology, Grant Medical College & Sir JJ Group of Hospitals Mumbai, India.
Clinical Pharmacologist, formerly affiliated to Department of Pharmacology, Seth GS Medical College & KEM hospital Mumbai, India.
出版信息
Front Pharmacol. 2014 Jun 16;5:143. doi: 10.3389/fphar.2014.00143. eCollection 2014.
Abstract
摘要
相似文献
1
Are trial participants adequately safeguarded by the ethics committees-the Indian scenario?
Front Pharmacol. 2014 Jun 16;5:143. doi: 10.3389/fphar.2014.00143. eCollection 2014.
2
Consultation-liaison psychiatrists on bioethics committees: opportunities for academic leadership.
Acad Psychiatry. 2006 Sep-Oct;30(5):416-21. doi: 10.1176/appi.ap.30.5.416.
3
Clinical Bioethics Committees: a Brazilian experience.
J Int Bioethique. 2008 Mar-Jun;19(1-2):181-92, 207. doi: 10.3917/jib.191.0181.
4
Institutional ethics committees. Committee on Bioethics.
Pediatrics. 2001 Jan;107(1):205-9. doi: 10.1542/peds.107.1.205.
5
Central institutional ethics committee needed to facilitate timely review of multicenter clinical trials.
J Postgrad Med. 2019 Apr-Jun;65(2):107-109. doi: 10.4103/jpgm.JPGM_428_18.
6
An overview of trends in the regulation of clinical ethics committees: an opinion from the Italian National Bioethics Committee article.
Cuad Bioet. 2018 Sep-Dec;29(97):221-231.
7
Avoiding conflicts of interest in surrogate decision making: why ethics committees should assign surrogacy to a separate committee.
J Clin Ethics. 1998 Fall;9(3):273-90.
8
Justice in jeopardy: a qualitative study of institutional ethics committees in New Delhi.
Indian J Med Ethics. 2013 Jul-Sep;10(3):176-83. doi: 10.20529/IJME.2013.053.
9
Toward increased public representation on bioethics committees: lessons from judging the Cold War human radiation experiments.
Account Res. 1999;6(3):183-203. doi: 10.1080/08989629908573927.
10
[Experience in the global forum of bioethics in research. Challenges for the ethical review in Chile].
Rev Med Chil. 2018 May;146(5):653-659. doi: 10.4067/s0034-98872018000500653.
本文引用的文献
1
US-funded measurements of cervical cancer death rates in India: scientific and ethical concerns.
Indian J Med Ethics. 2014 Jul-Sep;11(3):167-75. doi: 10.20529/IJME.2014.046. Epub 2014 Apr 17.
2
Are institutional review boards prepared for active continuing review?
Perspect Clin Res. 2014 Jan;5(1):11-5. doi: 10.4103/2229-3485.124553.
3
Indian regulatory update 2013.
Perspect Clin Res. 2013 Oct;4(4):237-8. doi: 10.4103/2229-3485.120174.
4
Ethics of 'standard care' in randomised controlled trials of screening for cervical cancer.
Indian J Med Ethics. 2013 Jul-Sep;10(3):147-9. doi: 10.20529/IJME.2013.048.
5
Conflict of interest and its importance.
Perspect Clin Res. 2013 Jan;4(1):41-4. doi: 10.4103/2229-3485.106375.
6
Ethics committees in India: Facing the challenges!
Perspect Clin Res. 2012 Apr;3(2):50-6. doi: 10.4103/2229-3485.96444.
7
A study of warning letters issued to clinical investigators and institutional review boards by the United States Food and Drug Administration.
Indian J Med Ethics. 2011 Oct-Dec;8(4):211-4. doi: 10.20529/IJME.2011.082.
8
Institutional ethics committees: critical gaps.
Indian J Med Ethics. 2011 Oct-Dec;8(4):200-1. doi: 10.20529/IJME.2011.080.
9
Competence of ethics committees in patient protection in clinical research.
Indian J Med Ethics. 2011 Jul-Sep;8(3):151-4. doi: 10.20529/IJME.2011.061.
10
Quality of independent review board/ethics committee oversight in clinical trials in India.
Perspect Clin Res. 2011 Apr;2(2):45-7. doi: 10.4103/2229-3485.80364.
Zotero 插件